Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
St. Louis, MO
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Washington University Therapeutics (WT) CRS
mi
from
St. Louis, MO
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Camden, NJ
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Cooper Univ. Hosp. CRS
mi
from
Camden, NJ
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Newark, NJ
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
New Jersey Medical School Clinical Research Center CRS
mi
from
Newark, NJ
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Newark, NJ
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Rutgers - New Jersey Medical School CRS
mi
from
Newark, NJ
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Bronx, NY
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Bronx-Lebanon Hosp. Ctr. CRS
mi
from
Bronx, NY
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
New York, NY
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Weill Cornell Chelsea CRS
mi
from
New York, NY
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
New York, NY
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
New York, NY
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Nyu Ny Nichd Crs
mi
from
New York, NY
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
New York, NY
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Metropolitan Hosp. NICHD CRS
mi
from
New York, NY
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
New York, NY
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Columbia P&S CRS
mi
from
New York, NY
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
New York, NY
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Columbia IMPAACT CRS
mi
from
New York, NY
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
New York, NY
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Harlem ACTG CRS
mi
from
New York, NY
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Rochester, NY
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Trillium Health ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Rochester, NY
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Chapel Hill, NC
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Chapel Hill CRS
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Durham, NC
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Duke Univ. Med. Ctr. Adult CRS
mi
from
Durham, NC
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Cincinnati, OH
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Cincinnati CRS
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Cleveland, OH
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Case Clinical Research Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Cleveland, OH
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
MetroHealth CRS
mi
from
Cleveland, OH
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Columbus, OH
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Ohio State University CRS
mi
from
Columbus, OH
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Portland, OR
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
The Research & Education Group-Portland CRS
mi
from
Portland, OR
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Philadelphia, PA
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Penn Therapeutics Crs
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Philadelphia, PA
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Thomas Jefferson Univ. Med. Ctr. CRS
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Pittsburgh, PA
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
University of Pittsburgh CRS
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Providence, RI
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
The Miriam Hospital Clinical Research Site (TMH CRS) CRS
mi
from
Providence, RI
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Memphis, TN
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
St. Jude Children's Research Hospital CRS
mi
from
Memphis, TN
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Nashville, TN
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Vanderbilt Therapeutics (VT) CRS
mi
from
Nashville, TN
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Dallas, TX
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Trinity Health and Wellness Center CRS
mi
from
Dallas, TX
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Houston, TX
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Houston AIDS Research Team CRS
mi
from
Houston, TX
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Houston, TX
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Texas Children's Hosp. CRS
mi
from
Houston, TX
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Richmond, VA
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Virginia Commonwealth Univ. Medical Ctr. CRS
mi
from
Richmond, VA
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
Seattle, WA
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
University of Washington AIDS CRS
mi
from
Seattle, WA
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated:  12/8/2015
mi
from
San Juan,
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Puerto Rico AIDS Clinical Trials Unit CRS
mi
from
San Juan,
Click here to add this to my saved trials
Assessing the Safety of Dapivirine Gel and Film Formulations
Status: Enrolling
Updated:  12/8/2015
mi
from
Pittsburgh, PA
Assessing the Safety of Dapivirine Gel and Film Formulations
Status: Enrolling
Updated: 12/8/2015
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Randomized Control Trial of Family-Based HIV Prevention for Latinos
A Randomized Controlled Trial of Family-Based HIV Prevention for Latino Youth
Status: Enrolling
Updated:  12/8/2015
mi
from
Tampa, FL
Randomized Control Trial of Family-Based HIV Prevention for Latinos
A Randomized Controlled Trial of Family-Based HIV Prevention for Latino Youth
Status: Enrolling
Updated: 12/8/2015
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
San Francisco, CA
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Ucsf Aids Crs
mi
from
San Francisco, CA
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
Atlanta, GA
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Ponce de Leon Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
Pittsburgh, PA
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Pitt CRS
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
Los Angeles, CA
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Usc Crs
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
Los Angeles, CA
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
Torrance, CA
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Harbor-UCLA Med. Ctr. CRS
mi
from
Torrance, CA
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
Aurora, CO
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
University of Colorado Hospital CRS (6101)
mi
from
Aurora, CO
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
Chicago, IL
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Northwestern University CRS (2701)
mi
from
Chicago, IL
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
Chicago, IL
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Rush University Medical Center (2702)
mi
from
Chicago, IL
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
Baltimore, MD
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Johns Hopkins Adult AIDS CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
Boston, MA
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Brigham and Women's Hosp. ACTG CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
Boston, MA
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Beth Israel Deaconess Med. Ctr., ACTG CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
St. Louis, MO
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Washington University CRS (2101)
mi
from
St. Louis, MO
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
Newark, NJ
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
New Jersey Medical School- Adult Clinical Research Ctr. CRS
mi
from
Newark, NJ
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated:  12/9/2015
mi
from
New York, NY
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
NY Univ. HIV/AIDS CRS (401)
mi
from
New York, NY
Click here to add this to my saved trials